C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP

Analytical and Bioanalytical Chemistry

Volumn 401, Issue 4, 2011, Pages 1309-1318

  Wang, Min S ^a   Black, Joshua C ^b   Knowles, Michelle K ^b   Reed, Scott M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF DENVER   (United States)

Author keywords

Aptamer; C reactive protein; Cardiovascular disease; Fluorescence anisotropy; Isoform; TIRF microscopy

Indexed keywords

APTAMERS; C-REACTIVE PROTEINS; CARDIOVASCULAR DISEASE; FLUORESCENCE ANISOTROPY; ISOFORMS; TIRF MICROSCOPY;

ANISOTROPY; CELL MEMBRANES; CYTOLOGY; DISEASES; FLUORESCENCE; FLUORESCENCE MICROSCOPY; REFRACTIVE INDEX; RNA; SODIUM; SODIUM SULFATE;

PROTEINS;

APTAMER; C REACTIVE PROTEIN; ISOPROTEIN;

ARTICLE; CHEMISTRY; FLUORESCENCE POLARIZATION; HUMAN; LIMIT OF DETECTION; METABOLISM; PROTEIN BINDING; TIME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

APTAMERS, NUCLEOTIDE; C-REACTIVE PROTEIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENCE POLARIZATION; HUMANS; LIMIT OF DETECTION; PROTEIN BINDING; PROTEIN ISOFORMS; TIME FACTORS;

EID: 80052602651     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5174-1     Document Type: Article

References (48)

1. S Black I Kushner D Samols 2004 C-reactive protein J Biol Chem 279 47 48487 48490 10.1074/jbc.R400025200 1:CAS:528:DC%2BD2cXpslGqtrw%3D (Pubitemid 39625721)
2. SR Ji Y Wu L Zhu LA Potempa FL Sheng W Lu J Zhao 2007 Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m) FASEB J 21 1 284 294 10.1096/fj.06-6722com 1:CAS:528:DC%2BD2sXmvFChsQ%3D%3D (Pubitemid 46052567)
3. MB Pepys GM Hirschfield 2003 C-reactive protein: a critical update J Clin Invest 111 12 1805 1812 1:CAS:528:DC%2BD3sXkvV2ktb0%3D (Pubitemid 38057722)
4. D Thompson MB Pepys SP Wood 1999 The physiological structure of human C-reactive protein and its complex with phosphocholine Struct Fold Des 7 2 169 177 10.1016/S0969-2126(99)80023-9 1:CAS:528:DyaK1MXhsFeltLk%3D (Pubitemid 29159702)
5. JE Volanakis 2001 Human C-reactive protein: expression, structure, and function Mol Immunol 38 2-3 189 197 10.1016/S0161-5890(01)00042-6 1:CAS:528:DC%2BD3MXmt1Gmsb4%3D (Pubitemid 32786776)
6. LA Potempa BA Maldonado P Laurent ES Zemel H Gewurz 1983 Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium Mol Immunol 20 11 1165 1175 10.1016/0161-5890(83)90140-2 1:CAS:528:DyaL2cXitFaisw%3D%3D (Pubitemid 14230026)
7. LA Potempa JN Siegel BA Fiedel RT Potempa H Gewurz 1987 Expression, detection and assay of a neoantigen (Neo-Crp) associated with a free, human C-reactive protein subunit Mol Immunol 24 5 531 541 10.1016/0161-5890(87)90028-9 1:CAS:528:DyaL2sXktlOlu74%3D (Pubitemid 17062643)
8. LA Potempa JM Zeller BA Fiedel CM Kinoshita H Gewurz 1988 Stimulation of human-neutrophils, monocytes, and platelets by modified C-reactive protein (Crp) expressing a neoantigenic specificity Inflammation 12 4 391 405 10.1007/BF00915774 1:CAS:528:DyaL1cXlsVOnsr8%3D
9. KE Taylor CW van den Berg 2007 Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein Immunology 120 3 404 411 10.1111/j.1365-2567.2006.02516.x 1:CAS:528: DC%2BD2sXisVylt70%3D (Pubitemid 46232915)
10. SK Singh MV Suresh DJ Hammond AE Rusinol LA Potempa A Agrawal 2009 Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine Clin Chimica Acta 406 1-2 151 155 10.1016/j.cca.2009.06.018 1:CAS:528:DC%2BD1MXoslCqs7c%3D
11. SU Eisenhardt JR Thiele H Bannasch GB Stark K Peter 2009 C-reactive protein: how conformational changes influence inflammatory properties Cell Cycle 8 23 3885 3892 10.4161/cc.8.23.10068 1:CAS:528:DC%2BC3cXotlWrtLY%3D
12. T Khreiss L Jozsef LA Potempa JG Filep 2004 Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells Circulation 109 16 2016 2022 10.1161/01.CIR.0000125527.41598. 68 1:CAS:528:DC%2BD2cXjtFOmtrs%3D (Pubitemid 38544493)
13. SU Eisenhardt J Habersberger A Murphy YC Chen KJ Woollard N Bassler HW Qian C von zur Muhlen CE Hagemeyer I Ahrens J Chin-Dusting A Bobik K Peter 2009 Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques Circ Res 105 2 128 155 10.1161/CIRCRESAHA.108.190611 1:CAS:528:DC%2BD1MXot1ektro%3D
14. D Gershov S Kim N Brot KB Elkon 2000 C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity J Exp Med 192 9 1353 1363 10.1084/jem.192.9.1353 1:CAS:528:DC%2BD3cXnvFWgtLw%3D
15. PM van der Zee E Biro LA Trouw Y Ko RJ de Winter CE Hack A Sturk R Nieuwland 2010 C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation Clin Immunol 135 3 490 495 10.1016/j.clim.2010.01.002
16. JE Volanakis AJ Narkates 1981 Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement J Immunol 126 5 1820 1825 1:CAS:528:DyaL3MXhvFSiu78%3D (Pubitemid 11120965)
17. MK Chang CJ Binder M Torzewski JL Witztum 2002 C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids Proc Natl Acad Sci USA 99 20 13043 13048 10.1073/pnas.192399699 1:CAS:528:DC%2BD38XnvFGhtb0%3D
18. SC Ying H Gewurz CM Kinoshita LA Potempa JN Siegel 1989 Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies J Immunol 143 1 221 228 1:CAS:528:DyaL1MXkslKjtL4%3D (Pubitemid 19174224)
19. SR Ji Y Wu LA Potempa YH Liang J Zhao 2006 Effect of modified C-reactive protein on complement activation-a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions Arterioscl Throm Vas 26 4 935 941 10.1161/01.ATV.0000206211.21895.73 1:CAS:528: DC%2BD28XitlKmtL0%3D (Pubitemid 43732175)
20. C Zouki B Haas JSD Chan LA Potempa JG Filep 2001 Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion J Immunol 167 9 5355 5361 1:CAS:528:DC%2BD3MXotVWjtrs%3D (Pubitemid 33009775)
21. PM Ridker N Rifai L Rose JE Buring NR Cook 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events New Engl J Med 347 20 1557 1565 10.1056/NEJMoa021993 1:CAS:528:DC%2BD38Xos1KhsL0%3D (Pubitemid 35315836)
22. AD Ellington JW Szostak 1990 In vitro selection of RNA molecules that bind specific ligands Nature 346 6287 818 822 10.1038/346818a0 1:CAS:528:DyaK3MXitVGgsw%3D%3D (Pubitemid 20272100)
23. C Tuerk L Gold 1990 Systematic evolution of ligands by exponential enrichment-RNA ligands to bacteriophage-T4 DNA-polymerase Science 249 4968 505 510 10.1126/science.2200121 1:CAS:528:DyaK3cXlt1OltLY%3D
24. S Tombelli A Minunni A Mascini 2005 Analytical applications of aptamers Biosens Bioelectron 20 12 2424 2434 10.1016/j.bios.2004.11.006 1:CAS:528:DC%2BD2MXjs1Knt7s%3D (Pubitemid 40602182)
25. V Pavlov Y Xiao B Shlyahovsky I Willner 2004 Aptamer-functionalized Au nanoparticles for the amplified optical detection of thrombin J Am Chem Soc 126 38 11768 11769 10.1021/ja046970u 1:CAS:528:DC%2BD2cXnt1eht7c%3D (Pubitemid 39298307)
26. Y Xiao AA Lubin AJ Heeger KW Plaxco 2005 Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor Angew Chem Int Edit 44 34 5456 5459 10.1002/anie.200500989 1:CAS:528:DC%2BD2MXpvF2ksLg%3D (Pubitemid 41273294)
27. Y Xiao BD Piorek KW Plaxco AJ Heeger 2005 A reagentless signal-on architecture for electronic, aptamer-based sensors via target-induced strand displacement J Am Chem Soc 127 51 17990 17991 10.1021/ja056555h 1:CAS:528:DC%2BD2MXht1Gru7zF (Pubitemid 43038446)
28. M Minunni S Tombelli A Gullotto E Luzi M Mascini 2004 Development of biosensors with aptamers as bio-recognition element: the case of HIV-1 Tat protein Biosens Bioelectron 20 6 1149 1156 10.1016/j.bios.2004.03.037 1:CAS:528:DC%2BD2cXhtVSntLvK (Pubitemid 39535573)
29. S Tombelli A Minunni E Luzi M Mascini 2005 Aptamer-based biosensors for the detection of HIV-1 Tat protein Bioelectrochemistry 67 2 135 141 10.1016/j.bioelechem.2004.04.011 1:CAS:528:DC%2BD2MXptVWntLY%3D (Pubitemid 41191208)
30. A Bini S Centi S Tombelli M Minunni M Mascini 2008 Development of an optical RNA-based aptasensor for C-reactive protein Anal Bioanal Chem 390 4 1077 1086 10.1007/s00216-007-1736-7 1:CAS:528:DC%2BD1cXhsFamt7w%3D
31. CJ Huang HI Lin SC Shiesh GB Lee 2010 Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX) Biosens Bioelectron 25 7 1761 1766 10.1016/j.bios.2009.12.029 1:CAS:528:DC%2BC3cXitVOnt7g%3D
32. Kim SD, Ryu JS, Yi H-K, Kim S-C, Zhang B-T (2004) Construction of C-reactive protein-binding aptamer as a module of the DNA computing system for diagnosing cardiovascular diseases. In: Preliminary proceedings of the tenth international meeting on DNA computing (DNA10):334-343
33. R Stoltenburg C Reinemann B Strehlitz 2005 FluMag-SELEX as an advantageous method for DNA aptamer selection Anal Bioanal Chem 383 1 83 91 10.1007/s00216-005-3388-9 1:CAS:528:DC%2BD2MXhtFKhtrzF (Pubitemid 41549245)
34. A Biro Z Rovo D Papp L Cervenak L Varga G Fust NM Thielens GJ Arlaud Z Prohaszka 2007 Studies on the interactions between C-reactive protein and complement proteins Immunology 121 1 40 50 10.1111/j.1365-2567.2007.02535.x 1:CAS:528:DC%2BD2sXltFarsbo%3D (Pubitemid 46537662)
35. D Toomre DJ Manstein 2001 Lighting up the cell surface with evanescent wave microscopy Trends Cell Biol 11 7 298 303 10.1016/S0962-8924(01)02027-X 1:CAS:528:DC%2BD3MXksVyntbw%3D (Pubitemid 32537776)
36. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 10.1038/227680a0 1:CAS:528:DC%2BD3MXlsFags7s%3D
37. W Li KM Wang WH Tan CB Ma XH Yang 2007 Aptamer-based analysis of angiogenin by fluorescence anisotropy Analyst 132 2 107 113 10.1039/b614138b 1:CAS:528:DC%2BD2sXhtVKhtr8%3D (Pubitemid 46169507)
38. MR Mackiewicz HL Hodges SM Reed 2010 C-reactive protein induced rearrangement of phosphatidylcholine on nanoparticle mimics of lipoprotein particles J Phys Chem B 114 16 5556 5562 10.1021/jp911617q 1:CAS:528: DC%2BC3cXkt1Grsrs%3D
39. TG McCauley N Hamaguchi M Stanton 2003 Aptamer-based biosensor arrays for detection and quantification of biological macromolecules Anal Biochem 319 2 244 250 10.1016/S0003-2697(03)00297-5 1:CAS:528:DC%2BD3sXlsVSnu7g%3D (Pubitemid 36842733)
40. S D'Auria R Barone M Rossi R Nucci G Barone D Fessas E Bertoli F Tanfani 1997 Effects of temperature and SDS on the structure of beta-glycosidase from the thermophilic archaeon Sulfolobus solfataricus Biochem J 323 833 840 (Pubitemid 27202356)
41. A Agrawal AK Shrive TJ Greenhough JE Volanakis 2001 Topology and structure of the C1q-binding site on C-reactive protein J Immunol 166 6 3998 4004 1:CAS:528:DC%2BD3MXitVGms70%3D (Pubitemid 32224928)
42. EE Diehl GK Haines 3rd JA Radosevich LA Potempa 2000 Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue Am J Med Sci 319 2 79 83 10.1097/00000441-200002000-00002 1:STN:280: DC%2BD3c7mtF2itA%3D%3D (Pubitemid 30349650)
43. M Wagner P Weber T Bruns WSL Strauss R Wittig H Schneckenburger 2010 Light dose is a limiting factor to maintain cell viability in fluorescence microscopy and single molecule detection Int J Mol Sci 11 3 956 966 10.3390/ijms11030956 1:CAS:528:DC%2BC3cXjsVequ7g%3D
44. SB Schwedler F Guderian J Dammrich LA Potempa C Wanner 2003 Tubular staining of modified C-reactive protein in diabetic chronic kidney disease Nephrol Dial Transpl 18 11 2300 2307 10.1093/ndt/gfg407 1:CAS:528: DC%2BD3sXot1GjtrY%3D (Pubitemid 37336817)
45. P Vaith LA Potempa 2000 Deposition of modified or native C-reactive protein in atherosclerotic arteries? Arterioscl Throm Vas 20 4 1173 1174 10.1161/01.ATV.20.4.1173 1:STN:280:DC%2BD3c3jtVajtw%3D%3D
46. WP Hu HY Hsu A Chiou KY Tseng HY Lin GL Chang SJ Chen 2006 Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing Biosens Bioelectron 21 8 1631 1637 10.1016/j.bios.2005.11.001 1:CAS:528:DC%2BD28XovVSisw%3D%3D (Pubitemid 43122031)
47. SK Singh MV Suresh DJ Hammond Jr AE Rusinol LA Potempa A Agrawal 2009 Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine Clin Chim Acta 406 1-2 151 155 10.1016/j.cca.2009.06.018 1:CAS:528:DC%2BD1MXoslCqs7c%3D
48. T Khreiss L Jozsef S Hossain JSD Chan LA Potempa JG Filep 2002 Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils J Biol Chem 277 43 40775 40781 10.1074/jbc.M205378200 1:CAS:528:DC%2BD38XnvFyntbY%3D (Pubitemid 35215662)